SUPPRESSION OF 24-HOUR CHOLECYSTOKININ SECRETION BY ORAL-CONTRACEPTIVES

被引：14
|
作者：
KARLSSON, R
LINDEN, A
VONSCHOULTZ, B
机构：
[1] KAROLINSKA HOSP,DEPT OBSTET & GYNECOL,S-10401 STOCKHOLM 60,SWEDEN
[2] UMEA UNIV,DEPT FAMILY MED,S-90187 UMEA,SWEDEN
来源：
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 1992年 / 167卷 / 01期
关键词：
ORAL CONTRACEPTIVES; CHOLECYSTOKININ; SECRETORY PROFILE;
D O I：
10.1016/S0002-9378(11)91626-3
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Weight gain is a common side effect during oral contraceptive use. The secretion of the satiety hormone cholecystokinin was recorded for 24 hours in women before and during treatment with oral contraceptives. During treatment serum profiles of cholecystokinin were clearly suppressed, which might be related to increased appetite and weight gain.
引用
收藏
页码：58 / 59
页数：2
相关论文
共 50 条
  • [1] Low-dose oral contraceptives and 24-hour ambulatory blood pressure
    Cardoso, F
    Polónia, J
    Santos, A
    Silva-Carvalho, J
    Ferreira-de-Almeida, J
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1997, 59 (03) : 237 - 243
  • [2] INTERACTIONS WITH ORAL-CONTRACEPTIVES
    FOTHERBY, K
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (06) : 2153 - 2159
  • [3] COMPLIANCE AND ORAL-CONTRACEPTIVES - A REVIEW
    ROSENBERG, MJ
    BURNHILL, MS
    WAUGH, MS
    GRIMES, DA
    HILLARD, PJA
    CONTRACEPTION, 1995, 52 (03) : 137 - 141
  • [4] PULMONARY EMBOLUS IN AN ADOLESCENT ON ORAL-CONTRACEPTIVES
    KEY, JD
    HAMMILL, WW
    EVERETT, L
    JOURNAL OF ADOLESCENT HEALTH, 1992, 13 (08) : 713 - 715
  • [5] ORAL-CONTRACEPTIVES, FIBRINOGEN AND CARDIOVASCULAR RISK
    ERNST, E
    ATHEROSCLEROSIS, 1992, 93 (1-2) : 1 - 5
  • [6] ORAL-CONTRACEPTIVES AND THE RISK OF ENDOMETRIAL CANCER
    LEVI, F
    LAVECCHIA, C
    GULIE, C
    NEGRI, E
    MONNIER, V
    FRANCESCHI, S
    DELALOYE, JF
    DEGRANDI, P
    CANCER CAUSES & CONTROL, 1991, 2 (02) : 99 - 103
  • [7] ORAL-CONTRACEPTIVES AND MYOCARDIAL-INFARCTION
    THORNEYCROFT, IH
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (04) : 1393 - 1397
  • [8] TYROSINE METABOLISM IN USERS OF ORAL-CONTRACEPTIVES
    MOLLER, SE
    MAACHMOLLER, B
    OLESEN, M
    MADSEN, B
    MADSEN, P
    FJALLAND, B
    LIFE SCIENCES, 1995, 56 (09) : 687 - 695
  • [9] THE EFFECT OF TETRACYCLINE ON LEVELS OF ORAL-CONTRACEPTIVES
    MURPHY, AA
    ZACUR, HA
    CHARACHE, P
    BURKMAN, RT
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 164 (01) : 28 - 33
  • [10] BENEFITS AND RISKS OF COMBINED ORAL-CONTRACEPTIVES
    VESSEY, MP
    METHODS OF INFORMATION IN MEDICINE, 1993, 32 (03) : 222 - 224
12345